author-photo

Teresa Paíno

University of Salamanca
Spanish National Research Council

46

Papers

534

Citations

Citation Trend

Filter By

Papers (27) Sort By

Journal Conference Others

Abstract 1291: The novel c-MYC inhibitor IDP-121 exhibits strong anti-myeloma effect

2021
Show All
- Source
- Cite
- Save
Citations (0)
DISSECTING THE BONE MARROW IMMUNE MICROENVIRONMENT IN THE COMPLETE SPECTRUM OF MONOCLONAL GAMMOPATHIES: POTENTIAL IMPLICATIONS IN DISEASE PATHOGENESIS: PS1352

2019
Show All
- Source
- Cite
- Save
Citations (0)
Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (18)
The novel pan-PIM kinase inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of care

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (31)
Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bortezomib and dexamethasone

2017 Haematologica
Show All
- Source
- Cite
- Save
Citations (7)
Immune Predictors of Response to Pembrolizumab Monotherapy As Consolidation in Multiple Myeloma Patients: Results of the GEM-Pembresid Clinical Trial

2017 Blood
Show All
- Source
- Cite
- Save
Citations (4)
Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

2017 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (19)
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional and circadian distribution profile Running title: Multiple myeloma circulating tumor cells Running head: Paiva et al

2017
Show All
- Source
- Cite
- Save
Citations (0)
Mechanisms Underlying the Synergistic Interaction of Filanesib with Pomalidomide and Dexamethasone (FPD) in Multiple Myeloma

2015 Blood
Show All
- Source
- Cite
- Save
Citations (0)
The novel pan-PIM kinase inhibitor, LGH447, shows dual antitumoral and bone antiresorptive effect in multiple myeloma and synergizes with standard-of-care treatments

2015 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)